PRIMARY SJÖGREN'S SYNDROME
Clinical trials for PRIMARY SJÖGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SJÖGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for PRIMARY SJÖGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Sjögren's sufferers
Disease control Recruiting nowThis study tests a new medication called IMVT-1402 for people with moderate to severe Sjögren's disease, an autoimmune condition causing dryness and other symptoms. About 180 adults will receive either the drug or a placebo to see if it reduces disease activity over 24 weeks. The…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New blood marker may help monitor Sjögren's flares
Knowledge-focused Recruiting nowThis study looks at whether a specific type of antibody in the blood, called anti-Ro/SSA IgE, can help doctors tell if Sjögren's syndrome is active. Researchers will measure this antibody in 185 people with primary Sjögren's and compare it to their disease activity scores. The go…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated May 17, 2026 10:46 UTC